MiniMed (MMED) Change in Receivables (2025 - 2026)
MiniMed (MMED) posted Change in Receivables of $161.0 million for Q3 2026, down 55.4% quarter-over-quarter from $361.0 million in Q2 2026, and up 3120.0% YoY from $5.0 million in Q3 2025.
Powered by 
Analysis
MiniMed (MMED) Change in Receivables (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of Change in Receivables data on file, last reported at $161.0 million in Q3 2026.
- For the quarter ending Q3 2026, Change in Receivables rose 3120.0% year-over-year to $161.0 million; the trailing twelve-month figure through Jul 2026 stood at $557.0 million (changed N/A YoY), and the FY2026 full-year result was $455.0 million, up 589.39% from the prior year.
- Change in Receivables was $161.0 million for Q3 2026 at MiniMed, down from $361.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $361.0 million in Q2 2026 to a low of $5.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -90.00 Mn |
| 10 | MiniMed | 6.37 Bn | 6.17 Bn | 465.00 Mn | 161.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 161.00 Mn |
| Apr 24, 2026 | 361.00 Mn |
| Apr 25, 2025 | 30.00 Mn |